Delivery Order SPE2DB20D7066-SPE2DB25FC2SJ

Award Date 3/23/25
Potential Completion Date 3/24/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,953.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, and has a completion date of February 20, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,916.03 firm fixed-price delivery order is for INFUVITE PEDIATRIC VIAL 5ML medical supplies, with a completion date of November 28, 2023. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,170.70 fixed-price delivery order contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a period of performance through December 26, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $26,480.58 and runs through July 24, 2024. It is a firm-fixed-price contract with no set-aside requirements. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award, valued at $13,671.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a medical product, with a completion date of June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,000.10 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a completion date of May 16, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $19,198.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a period of performance through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,190.29 firm fixed-price delivery order covers the provision of INFUVITE ADULT BULK VIAL 100ML medical products, with a period of performance through March 12, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, with a ceiling value of $2,522.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with an ultimate completion date of November 17, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2SJ
    Delivery Order

This federal contract award, valued at $2,404.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a completion date of March 24, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also encompasses a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition.

Generated 6/22/25, 9:43 AM